Medical Disclaimer: GLP-1 Guard is an independent consumer research publisher and does not provide medical advice, diagnosis, or prescription services. Content is for informational purposes only. Always consult a licensed healthcare provider before beginning any GLP-1 medication.
Affiliate Disclosure: We maintain editorial independence. When you sign up through links on our site, we may receive an affiliate referral commission at no additional cost to you. This compensation does not alter our factual pricing records or audit findings.
FDA Regulatory Advisory: Compounded semaglutide, tirzepatide, and other GLP-1 receptor agonists are prepared by state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities pursuant to valid patient-specific prescriptions. Compounded drugs are not FDA-approved, meaning the FDA does not evaluate their safety, efficacy, or quality prior to marketing. See official FDA advisories for complete information.
© 2026 GLP-1 Guard. All rights reserved. Independent research desk.Recorded dates and audit checks updated weekly.